CONFIRMATORY ANTIBODY FOR HEPATITIS C VIRUS (ANTI-HCV) - ANVISA Registration 80313210022
Access comprehensive regulatory information for CONFIRMATORY ANTIBODY FOR HEPATITIS C VIRUS (ANTI-HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80313210022 and manufactured by manufacturer not specified. The registration is held by MP BIOMEDICALS DO BRASIL LTDA with validity until Feb 22, 2026.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including BIO-RAD, FUJIREBIO EUROPE N.V., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80313210022
25351348223202058
07776689000190
Company Information
Dates and Status
Jun 01, 2020
22/02/2026
09/18/2025 19:00:01
ANTICORPO CONFIRMATÓRIO PARA VÍRUS DE HEPATITE C (ANTI-HCV)
INNO-LIA™ HCV Score <20T,CE> (80538)
FUJIREBIO EUROPE N.V.
80102512528
Aug 03, 2020
ANTICORPO CONFIRMATÓRIO PARA VÍRUS DE HEPATITE C (ANTI-HCV)
INNO-LIA™ HCV Score <20T,CE> (80538)
Not specified
80102512528
Aug 03, 2020
ANTICORPO CONFIRMATÓRIO PARA VÍRUS DE HEPATITE C (ANTI-HCV)
Família Geenius HCV Supplemental
Not specified
80020690405
Oct 14, 2019
ANTICORPO CONFIRMATÓRIO PARA VÍRUS DE HEPATITE C (ANTI-HCV)
Família Geenius HCV Supplemental
BIO-RAD
80020690405
Oct 14, 2019
ANTICORPO CONFIRMATÓRIO PARA VÍRUS DE HEPATITE C (ANTI-HCV)
DECISCAN HCV PLUS
BIO-RAD
80020690166
May 21, 2007

